$EVLO Evelo Biosciences, Inc. Insider Trading
Get free email notifications about insider trading in Evelo Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Evelo Biosciences, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Evelo Biosciences, Inc. for free.
CIK Number: 0001694665
IRS Number: 465594527
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: EVLO
Company Address: 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE 02139
Phone number: 617 870 8281
Former name: Evelo Therapeutics, Inc.
Former name: VL28, Inc.
Evelo Biosciences, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 03 2021 | EVLO | Evelo Biosciences, ... | Scavo Luca | CFO | Option Exercise | A | 0.00 | 4,545 | 0 | 4,545 | |
Jun 03 2021 | EVLO | Evelo Biosciences, ... | Scavo Luca | CFO | Option Exercise | A | 14.24 | 300,000 | 4,272,000 | 300,000 | |
Jun 03 2021 | EVLO | Evelo Biosciences, ... | Scavo Luca | CFO | Option Exercise | A | 0.00 | 4,545 | 0 | 4,545 | |
Jun 03 2021 | EVLO | Evelo Biosciences, ... | Scavo Luca | CFO | Option Exercise | A | 14.24 | 300,000 | 4,272,000 | 300,000 | |
Apr 13 2021 | EVLO | Evelo Biosciences, ... | McHugh Julie | Director | Option Exercise | A | 10.04 | 31,380 | 315,055 | 31,380 | |
Feb 04 2021 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 15.00 | 46,429 | 696,435 | 4,125,461 | 4.1 M to 4.1 M (+1.14 %) |
Feb 04 2021 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 15.00 | 37,143 | 557,145 | 1,370,476 | 1.3 M to 1.4 M (+2.79 %) |
Feb 04 2021 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 15.00 | 9,285 | 139,275 | 791,529 | 782.2 K to 791.5 K (+1.19 %) |
Feb 04 2021 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 15.00 | 37,143 | 557,145 | 3,207,312 | 3.2 M to 3.2 M (+1.17 %) |
Jan 29 2021 | EVLO | Evelo Biosciences, ... | GILL SIMBA | President & CEO | Option Exercise | A | 16.65 | 275,000 | 4,578,750 | 275,000 | |
Jan 29 2021 | EVLO | Evelo Biosciences, ... | Hohneker John | Director | Option Exercise | A | 16.65 | 31,380 | 522,477 | 31,380 | |
Jan 29 2021 | EVLO | Evelo Biosciences, ... | Bodmer Mark | CSO, President of R ... | Option Exercise | A | 16.65 | 179,000 | 2,980,350 | 179,000 | |
Jan 29 2021 | EVLO | Evelo Biosciences, ... | McHale Duncan | Chief Medical Offic ... | Option Exercise | A | 16.65 | 96,500 | 1,606,725 | 96,500 | |
Jan 29 2021 | EVLO | Evelo Biosciences, ... | Liu Xiaoli Jacqueline | Principal Accountin ... | Option Exercise | A | 0.00 | 5,680 | 0 | 5,680 | |
Jan 29 2021 | EVLO | Evelo Biosciences, ... | Liu Xiaoli Jacqueline | Principal Accountin ... | Option Exercise | A | 16.65 | 24,000 | 399,600 | 24,000 |